?:reviewBody
|
-
The hashtag #NobodyLikesTrump began trending on July 28, 2020, amid intense social media chatter about remarks U.S. President Donald Trump allegedly made earlier that day during a White House press briefing about the ongoing COVID-19 pandemic. Reportedly, Trump diverged from national issues in a momentary contemplation of his popularity, saying Nobody likes me in comments uncharacteristic of the often self-confident politician. It can only be my personality. That’s all, he concluded. Trump did, in fact, make these remarks, inspiring a Twitter frenzy that lasted into the next day. With more than 16,000 related tweets, #NobodyLikesTrump became the fourth most popular hashtag on Twitter’s July 29 trending list and sparked poor me news reports that played on Trump’s self-pity. The quote went viral after Trump was asked by a reporter to respond to since-deleted tweets in which he reportedly accused Dr. Anthony Fauci of misleading the country in his response to the coronavirus pandemic. Fauci has been the director of the National Institute of Allergy and Infectious Diseases since 1984 and became the face of the United States COVID-19 response at the onset of the pandemic. https://www.c-span.org/video/?474297-1/president-trump-coronavirus-news-conferenceIn a long-winded reply beginning around the 20-minute mark of the video, Trump said that he had a very good relationship with Dr. Fauci and that he listened to the adviser despite not always having agreed with his policies, particularly those related to the travel bans on China and Europe. Trump went on to speak to Fauci’s very good approval rating and described fellow White House Coronavirus Task Force member Dr. Deborah Birx as terrific. In subsequent comments, the president then questioned his own approval rating with respect to the virus and appeared to doubt his likability: During the 26-minute long press conference, the president also provided an update to COVID-19 vaccine trials and announced a $765 million loan to support the launch of Kodak Pharmaceuticals that will allow the film company to produce generic active pharmaceutical ingredients and make the key starting materials for many drugs.
(en)
|